compname says qtrly sales grew 15% to $1.3 billion.
qtrly sales grew 15% to $1.3 billion; underlying sales grew 14%.
q3 earnings per share was $0.54.
full year 2021 sales, earnings per share guidance range unchanged.
qtrly tavr sales of $858 million, up 15% on a reported basis.
tavr sales negatively impacted in last two months of q3 due to significant impact covid had on hospital resources.
